2-[(3S)-3-[((2S)-2-[[(2S)-2-[((2S)-5-amino-2-[[3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl)amino]-2-oxoazepanyl]acetic acid -Drug Synthesis Database

【结构式】

【分子编号】42816

【品名】2-[(3S)-3-[((2S)-2-[[(2S)-2-[((2S)-5-amino-2-[[3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl)amino]-2-oxoazepanyl]acetic acid

【CA登记号】

【分子式】C₃₆H₄₅N₇O₉

【分子量】719.79508

【元素组成】C 60.07% H 6.3% N 13.62% O 20%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号：(XXI)

Deprotection of the benzyl ester group of the N-terminal fragment (XX) by hydrogenolysis provided carboxylic acid (XXI). This was finally coupled with the C-terminal fragment (VIII) employing BOP reagent to furnish the title peptide derivative.

参考文献中间体

合成目标

【1】 Cristau, M.; et al.; Synthesis and biological evaluation of bombesin constrained analogues. J Med Chem 2000, 43, 12, 2356.

中间体序号	中间体编号	品名	分子式	供应商	用于合成
(VIII)	42807	(2S)-2-amino-N-[(1S)-2-hydroxy-1-isobutylhexyl]-3-(1H-imidazol-5-yl)propanamide	C₁₆H₃₀N₄O₂	详情	详情
(XX)	42815	benzyl 2-[(3S)-3-[((2S)-2-[[(2S)-2-[((2S)-5-amino-2-[[3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl)amino]-2-oxoazepanyl]acetate	C₄₃H₅₁N₇O₉	详情	详情
(XXI)	42816	2-[(3S)-3-[((2S)-2-[[(2S)-2-[((2S)-5-amino-2-[[3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl)amino]-2-oxoazepanyl]acetic acid	C₃₆H₄₅N₇O₉	详情	详情

Extended Information